Phosphodiesterase Isozymes
- 1 February 1998
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 157 (2) , 351-370
- https://doi.org/10.1164/ajrccm.157.2.9708012
Abstract
No abstract availableThis publication has 222 references indexed in Scilit:
- Cytokine production by phytohemagglutinin-stimulated human blood cells: Effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitorsInflammation Research, 1995
- The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-α and nitric oxideInternational Journal of Immunopharmacology, 1995
- Inhibition of allergen-induced lung eosinophilia by type-III and combined type III- and IV-selective phosphodiesterase inhibitors in Brown-Norway ratsInflammation Research, 1995
- Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitorInternational Journal of Immunopharmacology, 1994
- The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene familyGene, 1993
- A New Cyclic Nucleotide Phosphodiesterase Isozyme Expressed in the T-Lymphocyte Cell LinesBiochemical and Biophysical Research Communications, 1993
- New bronchodilators. 3. Imidazo[4,5-c][1,8]naphthyridin-4(5H)-onesJournal of Medicinal Chemistry, 1992
- Mechanism for the emetic side effect of xanthine bronchodilatorsLife Sciences, 1990
- High pressure liquid chromatography of cyclic nucleotide phosphodiesterase from purified human T-lymphocytesBiochemical and Biophysical Research Communications, 1989
- Relationships between adenosine, cyclic nucleotides, and xanthines in asthmaJournal of Allergy and Clinical Immunology, 1986